For-profit organizations · Montréal, Quebec
Pharma Glycovax Inc
- Total value
- $8.8M
- Agreements
- 3
- Programs
- 2
- First and latest
- 2018–2024
Federal grants and contributions, agreements starting Jan 2006 to Oct 2026, each counted once at its latest amended value. Source: Treasury Board proactive disclosure, published October 11, 2026. Agreements under programs that mostly fund individuals are not listed under any name.
See this recipient’s records on the government’s search
Applying for the same funding? NRC IRAP Financial Assistance (apply through the funder’s page; no deadline stated). Deadlines, who can apply and who else got it.
By program
| Program | Department | Agreements | Total |
|---|---|---|---|
| Industrial Research Assistance Program – Contributions to Firms | National Research Council Canada | 2 | $8.5M |
| The Regional Economic Growth Through Innovation Program (REGI) | Canada Economic Development for Quebec Regions | 1 | $250K |
By year
Funding by the year agreements started.
Show the numbers
| Year | Agreements | Total |
|---|---|---|
| 2018 | 1 | $50K |
| 2019 | 0 | $0 |
| 2020 | 1 | $8.5M |
| 2021 | 0 | $0 |
| 2022 | 0 | $0 |
| 2023 | 0 | $0 |
| 2024 | 1 | $250K |
Agreements
Newest first.
| Start | Program | What for | Value |
|---|---|---|---|
| Jun 2024 | The Regional Economic Growth Through Innovation Program (REGI)Canada Economic Development for Quebec Regions | Contribution | $250,000 |
| Aug 2020 | Industrial Research Assistance Program – Contributions to FirmsNational Research Council Canada | Réponse à la COVID-19 (VI) - First phase of testing in humansContribution | $8,477,787 |
| Apr 2018 | Industrial Research Assistance Program – Contributions to FirmsNational Research Council Canada | ARP - Development of rabbit antibodies for the detection of human cancerContribution | $50,000 |